Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 93

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 93
---
 Company considers to have been the most

<div align='center'>68</div>

important in linking Compensation Actually Paid to our PEO and other NEOs for 2024 to Company performance. We break out this table into two lists—one for our PEO and one for our other NEOs. The measures in this table are not ranked. Please refer to the Compensation Discussion and Analysis for detailed information about how we link executive compensation to performance.

| PEO                  |     | Non-PEO NEOs         |
| Net Product Revenues |     | Net Product Revenues |
| Stock Price          |     |                      |

Potential Payments upon Termi nation or a Change in Control The first table below reflects the amount of compensation payable to our President and Chief Executive Officer in the event of termination of his employment during the 90 days before and 24 months following a change in control or outside of such period. The second table below reflects the amount of compensation payable to each of our named executive officers, other than our President and Chief Executive Officer, in the event of termination of such executive’s employment within 12 months following a change in control or outside of such period. The amounts shown assume that change in control and such termination took place on December 31, 2024 based on the agreements in effect on that date, and thus includes amounts earned through such time and are estimates of the amounts which would be paid out to the named executive officers upon the occurrence of the relevant triggering event. President and Chief Executive Officer The amount of compensation payable to the President and Chief Executive Officer in the event of a termination of his employment without cause or his resignation for good reason (each such term, as defined in his employment agreement), in each case (i) during the 90 days before or the 24 months following a change in control and (ii) not in connection with the periods prior to or following a change in control described above, is shown below. The table below reflects the agreements with our President and Chief Executive Officer in place as of December 31, 2024.

| Name                                  |     | Benefit                                     |     | Qualifying         
 Termination of     
 Employment Not     
 in Connection with 
 Change             
 in Control(4)      |            |     | Qualifying         
 Termination of     
 Employment         
 in Connection with 
 Change             
 in Control (1)     |            |
|:--------------------------------------|:----|:--------------------------------------------|:----|:-------------------|-----------:|:----|:-------------------|-----------:|
|